Atlas Trials

An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

Clinical trial NCT03267576 · COMPLETED

Trial details

NCT number
NCT03267576
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2017-10-27
Primary completion
2018-10-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.